Pomegranate extract (35–150 μg/mL) has been shown to reduce survivin protein and gene expression and modulate its survivin pathway in prostate cancer cells (C4-2, PC3, ARCaPM). This evidence concerns the gene BIRC5 and prostate carcinoma.